Diabetes patients on colchicine after PCI show lower in-stent restenosis rates

04/29/2013 | Healio

Data on 196 diabetes patients who underwent percutaneous coronary intervention with a bare-metal stent showed those who received colchicine had an in-stent restenosis rate of 16%, compared with 33% in the placebo group. Colchicine-treated patients also had lower rates of late lumen loss than those in the control group, researchers wrote in the Journal of the American College of Cardiology.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
Washington DC, DC